Asosiy kontentga oʻtish
Maqola

Ўзбекистонда қалқонсимон безнинг дифференцияланган саратони: ретроспектив клиник кузатувлар ва GLOBOCAN 2024 эпидемиологик маълумотлари

Zamira KhalimovaРеспубликанский специализированный научно-практический медицинский центр эндокринологии имени академика Ё. Х. Туракулова, Ташкент, УзбекистанМуроджон ОмилжоновРеспубликанский специализированный научно-практический медицинский центр эндокринологии имени академика Ё. Х. Туракулова, Ташкент, УзбекистанMurodjon OmiljonovRepublican Specialized Scientific and Practical Medical Center of Endocrinology named after Academician Y.Kh. Turakulov , Tashkent , Uzbekistan
2026ru
ABI

Annotatsiya

A secondary descriptive analysis was conducted of a previously published clinical series of differentiated thyroid cancer (435 cases, 2010–2016), incorporating epidemiological estimates from GLOBOCAN 2024. According to archival summaries, 104 patients (23.9%) resided in Tashkent city and 62 (14.3%) in the Tashkent Region. Of the 435 cases, 215 (49.4%) were classified as papillary carcinoma, 211 (48.5%) as follicular carcinoma, and 9 (2.1%) as a mixed variant; a discrepancy in the original source concerning the latter category requires verification. According to GLOBOCAN 2024, an estimated 468 new cases and 71 deaths from thyroid cancer occurred in Uzbekistan in 2024. Data from a specialized center are not equivalent to national population-based indicators; directly calculating incidence trends from these two sources is methodologically unjustified. Population-based cancer registration and repeat morphological verification are needed to clarify epidemiological patterns.

Hali tarjima qilinmagan

Identifikatorlar

Iqtiboslar va manbalar